Global Tiapride Hydrochloride Tablets Market Growth 2026-2032

June 2026 | 88 pages | ID: GADC6125A371EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Tiapride Hydrochloride Tablets market size is predicted to grow from US$ 166 million in 2025 to US$ 221 million in 2032; it is expected to grow at a CAGR of 4.3% from 2026 to 2032.

Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain. It is used to treat a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly.

United States market for Tiapride Hydrochloride Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Tiapride Hydrochloride Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Tiapride Hydrochloride Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Tiapride Hydrochloride Tablets players cover Astellas Pharma, Nihon Generic, Sawai Pharmaceutical, Tasly Pharmaceuticals, Grand Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Tiapride Hydrochloride Tablets Industry Forecast? looks at past sales and reviews total world Tiapride Hydrochloride Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Tiapride Hydrochloride Tablets sales for 2026 through 2032. With Tiapride Hydrochloride Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tiapride Hydrochloride Tablets industry.

This Insight Report provides a comprehensive analysis of the global Tiapride Hydrochloride Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tiapride Hydrochloride Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tiapride Hydrochloride Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tiapride Hydrochloride Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tiapride Hydrochloride Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Tiapride Hydrochloride Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 100mg
  • 50mg
Segmentation by Application:
  • Hospital
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Astellas Pharma
  • Nihon Generic
  • Sawai Pharmaceutical
  • Tasly Pharmaceuticals
  • Grand Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Tianjin Pharmaceutical Da Ren Tang Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tiapride Hydrochloride Tablets market?
What factors are driving Tiapride Hydrochloride Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tiapride Hydrochloride Tablets market opportunities vary by end market size?
How does Tiapride Hydrochloride Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tiapride Hydrochloride Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Tiapride Hydrochloride Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Tiapride Hydrochloride Tablets by Country/Region, 2021, 2025 & 2032
2.2 Tiapride Hydrochloride Tablets Segment by Type
  2.2.1 100mg
  2.2.2 50mg
  2.2.3 Tiapride Hydrochloride Tablets Sales by Type
    2.2.3.1 Global Tiapride Hydrochloride Tablets Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Tiapride Hydrochloride Tablets Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Tiapride Hydrochloride Tablets Sale Price by Type (2021-2026)
2.3 Tiapride Hydrochloride Tablets Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Others
  2.3.4 Tiapride Hydrochloride Tablets Sales by Application
    2.3.4.1 Global Tiapride Hydrochloride Tablets Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Tiapride Hydrochloride Tablets Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Tiapride Hydrochloride Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Tiapride Hydrochloride Tablets Breakdown Data by Company
  3.1.1 Global Tiapride Hydrochloride Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Tiapride Hydrochloride Tablets Sales Market Share by Company (2021-2026)
3.2 Global Tiapride Hydrochloride Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Tiapride Hydrochloride Tablets Revenue by Company (2021-2026)
  3.2.2 Global Tiapride Hydrochloride Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Tiapride Hydrochloride Tablets Sale Price by Company
3.4 Key Manufacturers Tiapride Hydrochloride Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tiapride Hydrochloride Tablets Product Location Distribution
  3.4.2 Players Tiapride Hydrochloride Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TIAPRIDE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Tiapride Hydrochloride Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Tiapride Hydrochloride Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Tiapride Hydrochloride Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tiapride Hydrochloride Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Tiapride Hydrochloride Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Tiapride Hydrochloride Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tiapride Hydrochloride Tablets Sales Growth
4.4 APAC Tiapride Hydrochloride Tablets Sales Growth
4.5 Europe Tiapride Hydrochloride Tablets Sales Growth
4.6 Middle East & Africa Tiapride Hydrochloride Tablets Sales Growth

5 AMERICAS

5.1 Americas Tiapride Hydrochloride Tablets Sales by Country
  5.1.1 Americas Tiapride Hydrochloride Tablets Sales by Country (2021-2026)
  5.1.2 Americas Tiapride Hydrochloride Tablets Revenue by Country (2021-2026)
5.2 Americas Tiapride Hydrochloride Tablets Sales by Type (2021-2026)
5.3 Americas Tiapride Hydrochloride Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tiapride Hydrochloride Tablets Sales by Region
  6.1.1 APAC Tiapride Hydrochloride Tablets Sales by Region (2021-2026)
  6.1.2 APAC Tiapride Hydrochloride Tablets Revenue by Region (2021-2026)
6.2 APAC Tiapride Hydrochloride Tablets Sales by Type (2021-2026)
6.3 APAC Tiapride Hydrochloride Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tiapride Hydrochloride Tablets by Country
  7.1.1 Europe Tiapride Hydrochloride Tablets Sales by Country (2021-2026)
  7.1.2 Europe Tiapride Hydrochloride Tablets Revenue by Country (2021-2026)
7.2 Europe Tiapride Hydrochloride Tablets Sales by Type (2021-2026)
7.3 Europe Tiapride Hydrochloride Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tiapride Hydrochloride Tablets by Country
  8.1.1 Middle East & Africa Tiapride Hydrochloride Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Tiapride Hydrochloride Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Tiapride Hydrochloride Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Tiapride Hydrochloride Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tiapride Hydrochloride Tablets
10.3 Manufacturing Process Analysis of Tiapride Hydrochloride Tablets
10.4 Industry Chain Structure of Tiapride Hydrochloride Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tiapride Hydrochloride Tablets Distributors
11.3 Tiapride Hydrochloride Tablets Customer

12 WORLD FORECAST REVIEW FOR TIAPRIDE HYDROCHLORIDE TABLETS BY GEOGRAPHIC REGION

12.1 Global Tiapride Hydrochloride Tablets Market Size Forecast by Region
  12.1.1 Global Tiapride Hydrochloride Tablets Forecast by Region (2027-2032)
  12.1.2 Global Tiapride Hydrochloride Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tiapride Hydrochloride Tablets Forecast by Type (2027-2032)
12.7 Global Tiapride Hydrochloride Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Astellas Pharma
  13.1.1 Astellas Pharma Company Information
  13.1.2 Astellas Pharma Tiapride Hydrochloride Tablets Product Portfolios and Specifications
  13.1.3 Astellas Pharma Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Astellas Pharma Main Business Overview
  13.1.5 Astellas Pharma Latest Developments
13.2 Nihon Generic
  13.2.1 Nihon Generic Company Information
  13.2.2 Nihon Generic Tiapride Hydrochloride Tablets Product Portfolios and Specifications
  13.2.3 Nihon Generic Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Nihon Generic Main Business Overview
  13.2.5 Nihon Generic Latest Developments
13.3 Sawai Pharmaceutical
  13.3.1 Sawai Pharmaceutical Company Information
  13.3.2 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolios and Specifications
  13.3.3 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Sawai Pharmaceutical Main Business Overview
  13.3.5 Sawai Pharmaceutical Latest Developments
13.4 Tasly Pharmaceuticals
  13.4.1 Tasly Pharmaceuticals Company Information
  13.4.2 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Product Portfolios and Specifications
  13.4.3 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Tasly Pharmaceuticals Main Business Overview
  13.4.5 Tasly Pharmaceuticals Latest Developments
13.5 Grand Pharmaceutical
  13.5.1 Grand Pharmaceutical Company Information
  13.5.2 Grand Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolios and Specifications
  13.5.3 Grand Pharmaceutical Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Grand Pharmaceutical Main Business Overview
  13.5.5 Grand Pharmaceutical Latest Developments
13.6 Jiangsu Nhwa Pharmaceutical
  13.6.1 Jiangsu Nhwa Pharmaceutical Company Information
  13.6.2 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolios and Specifications
  13.6.3 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
  13.6.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.7 Tianjin Pharmaceutical Da Ren Tang Group
  13.7.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
  13.7.2 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Product Portfolios and Specifications
  13.7.3 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Tianjin Pharmaceutical Da Ren Tang Group Main Business Overview
  13.7.5 Tianjin Pharmaceutical Da Ren Tang Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Tiapride HydrochlorideTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tiapride HydrochlorideTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 100mg
Table 4. Major Players of 50mg
Table 5. Global Tiapride HydrochlorideTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Tiapride HydrochlorideTablets Sales Market Share by Type (2021-2026)
Table 7. Global Tiapride HydrochlorideTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Tiapride HydrochlorideTablets Revenue Market Share by Type (2021-2026)
Table 9. Global Tiapride HydrochlorideTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Tiapride HydrochlorideTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Tiapride HydrochlorideTablets Sale Market Share by Application (2021-2026)
Table 12. Global Tiapride HydrochlorideTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Tiapride HydrochlorideTablets Revenue Market Share by Application (2021-2026)
Table 14. Global Tiapride HydrochlorideTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Tiapride HydrochlorideTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Tiapride HydrochlorideTablets Sales Market Share by Company (2021-2026)
Table 17. Global Tiapride HydrochlorideTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Tiapride HydrochlorideTablets Revenue Market Share by Company (2021-2026)
Table 19. Global Tiapride HydrochlorideTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Tiapride HydrochlorideTablets Producing Area Distribution and Sales Area
Table 21. Players Tiapride HydrochlorideTablets Products Offered
Table 22. Tiapride HydrochlorideTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Tiapride HydrochlorideTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Tiapride HydrochlorideTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Tiapride HydrochlorideTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Tiapride HydrochlorideTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Tiapride HydrochlorideTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Tiapride HydrochlorideTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Tiapride HydrochlorideTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Tiapride HydrochlorideTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Tiapride HydrochlorideTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Tiapride HydrochlorideTablets Sales Market Share by Country (2021-2026)
Table 35. Americas Tiapride HydrochlorideTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Tiapride HydrochlorideTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Tiapride HydrochlorideTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Tiapride HydrochlorideTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Tiapride HydrochlorideTablets Sales Market Share by Region (2021-2026)
Table 40. APAC Tiapride HydrochlorideTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Tiapride HydrochlorideTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Tiapride HydrochlorideTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Tiapride HydrochlorideTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Tiapride HydrochlorideTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Tiapride HydrochlorideTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Tiapride HydrochlorideTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Tiapride HydrochlorideTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Tiapride HydrochlorideTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Tiapride HydrochlorideTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Tiapride HydrochlorideTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Tiapride HydrochlorideTablets
Table 52. Key Market Challenges & Risks of Tiapride HydrochlorideTablets
Table 53. Key Industry Trends of Tiapride HydrochlorideTablets
Table 54. Tiapride HydrochlorideTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Tiapride HydrochlorideTablets Distributors List
Table 57. Tiapride HydrochlorideTablets Customer List
Table 58. Global Tiapride HydrochlorideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Tiapride HydrochlorideTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Tiapride HydrochlorideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Tiapride HydrochlorideTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Tiapride HydrochlorideTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Tiapride HydrochlorideTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Tiapride HydrochlorideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Tiapride HydrochlorideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Tiapride HydrochlorideTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Tiapride HydrochlorideTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Tiapride HydrochlorideTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Tiapride HydrochlorideTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Tiapride HydrochlorideTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Tiapride HydrochlorideTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Astellas Pharma Basic Information, Tiapride HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Astellas Pharma Tiapride HydrochlorideTablets Product Portfolios and Specifications
Table 74. Astellas Pharma Tiapride HydrochlorideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Latest Developments
Table 77. Nihon Generic Basic Information, Tiapride HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Nihon Generic Tiapride HydrochlorideTablets Product Portfolios and Specifications
Table 79. Nihon Generic Tiapride HydrochlorideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Nihon Generic Main Business
Table 81. Nihon Generic Latest Developments
Table 82. Sawai Pharmaceutical Basic Information, Tiapride HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Sawai Pharmaceutical Tiapride HydrochlorideTablets Product Portfolios and Specifications
Table 84. Sawai Pharmaceutical Tiapride HydrochlorideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sawai Pharmaceutical Main Business
Table 86. Sawai Pharmaceutical Latest Developments
Table 87. Tasly Pharmaceuticals Basic Information, Tiapride HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Tasly Pharmaceuticals Tiapride HydrochlorideTablets Product Portfolios and Specifications
Table 89. Tasly Pharmaceuticals Tiapride HydrochlorideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Tasly Pharmaceuticals Main Business
Table 91. Tasly Pharmaceuticals Latest Developments
Table 92. Grand Pharmaceutical Basic Information, Tiapride HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Grand Pharmaceutical Tiapride HydrochlorideTablets Product Portfolios and Specifications
Table 94. Grand Pharmaceutical Tiapride HydrochlorideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Grand Pharmaceutical Main Business
Table 96. Grand Pharmaceutical Latest Developments
Table 97. Jiangsu Nhwa Pharmaceutical Basic Information, Tiapride HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Jiangsu Nhwa Pharmaceutical Tiapride HydrochlorideTablets Product Portfolios and Specifications
Table 99. Jiangsu Nhwa Pharmaceutical Tiapride HydrochlorideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Jiangsu Nhwa Pharmaceutical Main Business
Table 101. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 102. Tianjin Pharmaceutical Da Ren Tang Group Basic Information, Tiapride HydrochlorideTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Tianjin Pharmaceutical Da Ren Tang Group Tiapride HydrochlorideTablets Product Portfolios and Specifications
Table 104. Tianjin Pharmaceutical Da Ren Tang Group Tiapride HydrochlorideTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Tianjin Pharmaceutical Da Ren Tang Group Main Business
Table 106. Tianjin Pharmaceutical Da Ren Tang Group Latest Developments

LIST OF FIGURES

Figure 1. Picture of Tiapride HydrochlorideTablets
Figure 2. Tiapride HydrochlorideTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tiapride HydrochlorideTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Tiapride HydrochlorideTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tiapride HydrochlorideTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tiapride HydrochlorideTablets Sales Market Share by Country/Region (2025)
Figure 10. Tiapride HydrochlorideTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 100mg
Figure 12. Product Picture of 50mg
Figure 13. Global Tiapride HydrochlorideTablets Sales Market Share by Type in 2026
Figure 14. Global Tiapride HydrochlorideTablets Revenue Market Share by Type (2021-2026)
Figure 15. Tiapride HydrochlorideTablets Consumed in Hospital
Figure 16. Global Tiapride HydrochlorideTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Tiapride HydrochlorideTablets Consumed in Clinic
Figure 18. Global Tiapride HydrochlorideTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. Tiapride HydrochlorideTablets Consumed in Others
Figure 20. Global Tiapride HydrochlorideTablets Market: Others (2021-2026) & (K Units)
Figure 21. Global Tiapride HydrochlorideTablets Sale Market Share by Application (2025)
Figure 22. Global Tiapride HydrochlorideTablets Revenue Market Share by Application in 2026
Figure 23. Tiapride HydrochlorideTablets Sales by Company in 2026 (K Units)
Figure 24. Global Tiapride HydrochlorideTablets Sales Market Share by Company in 2026
Figure 25. Tiapride HydrochlorideTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global Tiapride HydrochlorideTablets Revenue Market Share by Company in 2026
Figure 27. Global Tiapride HydrochlorideTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Tiapride HydrochlorideTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Tiapride HydrochlorideTablets Sales 2021-2026 (K Units)
Figure 30. Americas Tiapride HydrochlorideTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC Tiapride HydrochlorideTablets Sales 2021-2026 (K Units)
Figure 32. APAC Tiapride HydrochlorideTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe Tiapride HydrochlorideTablets Sales 2021-2026 (K Units)
Figure 34. Europe Tiapride HydrochlorideTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Tiapride HydrochlorideTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Tiapride HydrochlorideTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas Tiapride HydrochlorideTablets Sales Market Share by Country in 2026
Figure 38. Americas Tiapride HydrochlorideTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas Tiapride HydrochlorideTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas Tiapride HydrochlorideTablets Sales Market Share by Application (2021-2026)
Figure 41. United States Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Tiapride HydrochlorideTablets Sales Market Share by Region in 2026
Figure 46. APAC Tiapride HydrochlorideTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC Tiapride HydrochlorideTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC Tiapride HydrochlorideTablets Sales Market Share by Application (2021-2026)
Figure 49. China Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Tiapride HydrochlorideTablets Sales Market Share by Country in 2026
Figure 57. Europe Tiapride HydrochlorideTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe Tiapride HydrochlorideTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe Tiapride HydrochlorideTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Tiapride HydrochlorideTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Tiapride HydrochlorideTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Tiapride HydrochlorideTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Tiapride HydrochlorideTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tiapride HydrochlorideTablets in 2026
Figure 74. Manufacturing Process Analysis of Tiapride HydrochlorideTablets
Figure 75. Industry Chain Structure of Tiapride HydrochlorideTablets
Figure 76. Channels of Distribution
Figure 77. Global Tiapride HydrochlorideTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global Tiapride HydrochlorideTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Tiapride HydrochlorideTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Tiapride HydrochlorideTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Tiapride HydrochlorideTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Tiapride HydrochlorideTablets Revenue Market Share Forecast by Application (2027-2032)


More Publications